Real-time enrollment status for this parkinson's disease clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 8:13 PM UTC
| NCT Number | NCT06976268 |
| Recruiting Status | Recruiting |
| Condition | Parkinson's Disease |
| Phase | PHASE2 |
| Target Enrollment | 550 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Biohaven Therapeutics Ltd. |
| Last Updated on CT.gov | July 10, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06976268 is currently recruiting participants. This phase2 study for parkinson's disease is actively seeking new participants at 15 locations across the United States. The study is sponsored by Biohaven Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06976268 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06976268 was last updated 1 week ago (July 10, 2026). HelloStudys verifies this status automatically.